Skip to main content
European Commission logo print header

Smart modular passive cool boxes for sustainable logistics

Project description

Innovative cold chain technology simplifies management of temperature-sensitive products

Cold chain plays a vital role across the pharmaceutical and biotechnological industries, ensuring that temperature-sensitive drugs, chemicals, blood plasma, tissue samples and diagnostic products remain stable during distribution and reach their destination undamaged. The EU-funded SmartCOOLBOX project is supporting Spain-based company INDUSTRIAL PROCESSES OUTSOURCING SERVICES SL in developing a logistics solution that simplifies transport management of goods that require a controlled temperature environment. The technology, which is offered as a service, relies on an intelligent, connected, reusable and modular isothermal container that reduces losses due to temperature excursions. With the SmartCOOLBOX innovation, pharma and biotech companies will be able to transport their temperature-sensitive goods in difficult-to-access areas.

Objective

SmartCOOLBOX is presented as a Logistic service for high-reliability temperature-controlled products, based on:
- SmartCOOLBOX itself, an intelligent, connected, reusable and modular ISOTHERMAL CONTAINER…
- … that is OFFERED AS A SERVICE, which simplifies the managing of the transport process

SmartCOOLBOX is an integrated combination of several innovations and technologies which feature:
- Use of light and degradable materials, offering longer life isothermal conditions range at the same time (warrantied
for 7 days, following the defined storage and handling conditions)
- Modularity and adaptation to actual goods measures
- Smart sensors for tracking the conditions of the transport
- Smart alerts system to track, and prevent or detect incidents, enabling rescue actions
- Reusability of boxes and materials
- Service covers the full supply chain, including reverse logistics

With SmartCOOLBOX, hospitals, labs and generic logistics operators may handle materials without relevant precautions,
increasing safety while decreasing costs. Pharma and biotech industries will reduce losses due to temperature excursions
and, at the same time, will open new markets such as difficult geographic areas, as well as disaster areas or in conflict
regions. From environmental perspective, savings will come by modular reusable boxes and less wasted products.

Call for proposal

H2020-EIC-SMEInst-2018-2020

See other projects for this call

Sub call

H2020-SMEInst-2018-2020-1

Coordinator

INDUSTRIAL PROCESSES OUTSOURCING SERVICES SL
Net EU contribution
€ 50 000,00
Address
CARRER DE ATLANTIC 112-120
08040 BARCELONA
Spain

See on map

SME

The organization defined itself as SME (small and medium-sized enterprise) at the time the Grant Agreement was signed.

Yes
Region
Este Cataluña Barcelona
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)
Links
Total cost
€ 71 429,00